Fiore Nathan T, Willcox Kendal F, Dayani Dorsa, Zuberi Younus A, Heijnen Cobi J, Grace Peter M
Laboratories of Neuroimmunology, Department of Symptom Research, University of Texas MD Anderson Cancer Center, Houston, USA.
Department of Psychological Sciences, Rice University, Houston, USA.
Brain Behav Immun. 2025 Mar;125:371-387. doi: 10.1016/j.bbi.2025.01.015. Epub 2025 Jan 25.
Preclinical and clinical studies have established that autoreactive immunoglobulin G (IgG) can drive neuropathic pain. We recently demonstrated that sciatic nerve chronic constriction injury (CCI) in male and female mice results in the production of pronociceptive IgG, which accumulates around the lumbar region, including within the dorsal root ganglia (DRG) and spinal cord, facilitating the development of neuropathic pain. These data raise the intriguing possibility that neuropathic pain may be alleviated by reducing the accumulation of IgG. To this end, we tested whether biologic inhibition or genetic deletion of the neonatal Fc receptor (FcRn) would attenuate mechanical hypersensitivity (allodynia) and IgG deposition induced by CCI. FcRn are prominently expressed on myeloid and endothelial cells and extend the half-life of IgG via pinocytosis and recycling into the extracellular milieu. We show here that administration of the FcRn blocker efgartigimod either 7- or 28-days post-CCI relieved allodynia among both male and female mice, compared to the Fc fragment control. Efgartigimod, administered systemically (intraperitoneal) or to the lumbar region (intrathecal), attenuated mechanical allodynia for at least one month. CCI-induced allodynia was similarly reduced in FcRn-deficient (FcRn) mice compared to wild-type mice. Biologic inhibition or genetic deletion of FcRn also reduced CCI-induced accumulation of IgG on macrophages and neurons in lumbar DRG, as well as microglia in the lumbar dorsal spinal cord. Expression of the Fc receptor γ subunit (FcRγ) was reduced in efgartigimod-treated or FcRn mice post-CCI compared to controls. The FcRγ subunit is a key component of Fc gamma receptors (FcγRs), which are activated by IgG immune complexes. In macrophage cultures stimulated by IgG immune complexes, FcRn blockade also dampened FcγR-dependent production of proinflammatory cytokines. Collectively, our study demonstrates that FcRn blockade or deletion alleviates mechanical allodynia and reduces IgG accumulation after CCI, attenuating pronociceptive IgG-FcγR signaling around the lumbar region. Strategies to block FcRn and reduce IgG recycling warrant further investigation as potential treatments for IgG-mediated neuropathic pain.
临床前和临床研究已证实,自身反应性免疫球蛋白G(IgG)可引发神经性疼痛。我们最近发现,雄性和雌性小鼠的坐骨神经慢性压迫损伤(CCI)会导致产生伤害感受性IgG,其在腰部区域积聚,包括背根神经节(DRG)和脊髓内,从而促进神经性疼痛的发展。这些数据引发了一种有趣的可能性,即通过减少IgG的积聚或许可以缓解神经性疼痛。为此,我们测试了对新生儿Fc受体(FcRn)进行生物学抑制或基因敲除是否会减轻CCI诱导的机械性超敏反应(异常性疼痛)和IgG沉积。FcRn在髓样细胞和内皮细胞上显著表达,并通过胞饮作用和再循环到细胞外环境中来延长IgG的半衰期。我们在此表明,在CCI后7天或28天给予FcRn阻断剂艾加莫德,与Fc片段对照组相比,可缓解雄性和雌性小鼠的异常性疼痛。艾加莫德通过全身(腹腔内)或腰部区域(鞘内)给药,可减轻机械性异常性疼痛至少一个月。与野生型小鼠相比,FcRn缺陷(FcRn-/-)小鼠中CCI诱导的异常性疼痛也同样减轻。对FcRn进行生物学抑制或基因敲除还可减少CCI诱导的IgG在腰部DRG的巨噬细胞和神经元以及腰部背侧脊髓的小胶质细胞上积聚。与对照组相比,在CCI后,经艾加莫德处理的小鼠或FcRn-/-小鼠中Fc受体γ亚基(FcRγ)的表达降低。FcRγ亚基是Fcγ受体(FcγRs)的关键组成部分,可被IgG免疫复合物激活。在由IgG免疫复合物刺激的巨噬细胞培养物中,FcRn阻断也可抑制FcγR依赖性促炎细胞因子的产生。总的来说,我们的研究表明,FcRn阻断或缺失可减轻CCI后的机械性异常性疼痛并减少IgG积聚,减弱腰部区域周围的伤害感受性IgG-FcγR信号传导。阻断FcRn并减少IgG再循环的策略作为IgG介导的神经性疼痛的潜在治疗方法值得进一步研究。